Coverage
-
March 01, 2017
A Delaware federal judge on Wednesday wiped out Genentech's newly filed lawsuit accusing Amgen of improperly concealing information about a proposed biosimilar of cancer drug Avastin, finding that the complaint isn't allowed under a landmark Federal Circuit ruling.
1 other articles on this case.
View all »